The role of non-HDL cholesterol in risk stratification for coronary artery disease

Jamal S Rana1, S Matthijs Boekholdt, John J P Kastelein

  • 1Division of Cardiology and Oppenheimer Atherosclerosis Research Center, Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. jamal.rana@cshs.org

Insights

Non-high-density lipoprotein cholesterol (non-HDL-C) effectively measures atherogenic particles and predicts coronary heart disease (CHD) risk. Measuring non-HDL-C is crucial for cardiovascular prevention strategies.

Area of Science:

  • Cardiovascular Medicine
  • Lipidology
  • Preventive Cardiology

Background:

  • Patients on lipid-lowering therapy remain at high risk for coronary heart disease (CHD).
  • Non-high-density lipoprotein cholesterol (non-HDL-C) quantifies cholesterol in all atherogenic particles.
  • Non-HDL-C was introduced as a secondary therapeutic target in the ATP III guidelines for patients with elevated triglycerides.

Purpose of the Study:

  • To evaluate the significance of non-HDL-C as a predictor of CHD risk.
  • To assess the utility of non-HDL-C compared to other lipid markers for cardiovascular risk assessment.
  • To advocate for the inclusion of non-HDL-C in routine lipid panels for guiding prevention strategies.

Main Methods:

  • Analysis of data from the EPIC-Norfolk prospective population study (21,448 participants).
  • Follow-up period of 11.0 years for participants aged 45-79 without diabetes or CHD.
  • Assessment of the relationship between non-HDL-C levels and CHD risk, independent of LDL-C.

Main Results:

  • High non-HDL-C levels were independently associated with increased CHD risk.
  • Non-HDL-C reduction correlates with CHD risk reduction, similar to LDL-C.
  • Non-HDL-C is a practical and cost-effective marker compared to apolipoprotein B.

Conclusions:

  • Non-HDL-C is a valuable and independent predictor of cardiovascular risk.
  • Routine reporting of non-HDL-C on lipid panels is recommended for improved cardiovascular prevention.
  • Future guidelines should emphasize non-HDL-C for guiding therapy and risk stratification.

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...